Beijing Tongrentang Co Ltd
SSE:600085

Watchlist Manager
Beijing Tongrentang Co Ltd Logo
Beijing Tongrentang Co Ltd
SSE:600085
Watchlist
Price: 32.94 CNY -0.21% Market Closed
Market Cap: 45.2B CNY
Section:
 

Relative Value

The Relative Value of one Beijing Tongrentang Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 32.94 CNY, Beijing Tongrentang Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Beijing Tongrentang Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
98
vs Industry
40
Median 3Y
3.2
Median 5Y
3.3
Industry
2.6
Forward
2.4
More Details
33.4
P/E
P/E
Price to Earnings
33.4
vs History
80
vs Industry
14
Median 3Y
35
Median 5Y
38.2
Industry
21.7
Forward
27.2
More Details
16.1
P/OCF
P/OCF
Price to OCF
16.1
vs History
76
vs Industry
4
Median 3Y
21.7
Median 5Y
18.4
Industry
16.6
More Details
19
P/FCFE
P/FCFE
Price to FCFE
19
vs History
84
vs Industry
10
Median 3Y
24.8
Median 5Y
23.9
Industry
22.5
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
96
vs Industry
18
Median 3Y
4.3
Median 5Y
4.5
Industry
2.3
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
60
vs Industry
45
Median 3Y
2.7
Median 5Y
2.8
Industry
2.9
Forward
2.5
More Details
6.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.2
vs History
46
vs Industry
38
Median 3Y
6.1
Median 5Y
6.1
Industry
5.5
More Details
21.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.2
vs History
34
vs Industry
24
Median 3Y
17.4
Median 5Y
17.6
Industry
13.1
Forward
14.7
More Details
21.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.2
vs History
34
vs Industry
28
Median 3Y
17.4
Median 5Y
17.6
Industry
16.6
Forward
17.1
More Details
17.3
EV/OCF
EV/OCF
Enterprise Value to OCF
17.3
vs History
36
vs Industry
4
Median 3Y
17.8
Median 5Y
16.2
Industry
15.8
More Details
20.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.6
vs History
47
vs Industry
1
Median 3Y
21.1
Median 5Y
20.2
Industry
19.1
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
93
vs Industry
29
Median 3Y
2.9
Median 5Y
3.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Beijing Tongrentang Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Tongrentang Co Ltd
SSE:600085
45.2B CNY 2.5 33.4 21.2 21.2
US
Eli Lilly and Co
NYSE:LLY
939.8B USD 15.8 51 34.3 36.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
497B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
256.4B CHF 4.2 27.2 11.6 13.6
UK
AstraZeneca PLC
LSE:AZN
209.6B GBP 4.8 29.8 108.8 159.3
CH
Novartis AG
SIX:NOVN
202.3B CHF 4.5 17.6 11.2 14.4
US
Merck & Co Inc
NYSE:MRK
242.8B USD 3.8 12.8 9.1 10.8
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.2 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
146.6B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
CN
Beijing Tongrentang Co Ltd
SSE:600085
Average P/E: 24.4
33.4
13%
2.6
US
Eli Lilly and Co
NYSE:LLY
51
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
17.6
17%
1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beijing Tongrentang Co Ltd
SSE:600085
Average EV/EBITDA: 399.7
21.2
17%
1.2
US
Eli Lilly and Co
NYSE:LLY
34.3
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.6
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beijing Tongrentang Co Ltd
SSE:600085
Average EV/EBIT: 1 709.6
21.2
7%
3
US
Eli Lilly and Co
NYSE:LLY
36.8
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.6
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.4
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.8
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.